The Kuhn-Hicks laboratory are using metal-tagged antibodies to map the proteins expressed on cancer cells circulating in the blood and in the bone marrow from a prostate cancer patient. The study, published in January by Convergent Science Physical Oncology, describes the approach of using an imaging mass cytometer to quantitate and localize 35 different protein markers... Read More
A new publication from Dr. James Hicks describing the utility of single-cell genomics from prostate biopsies towards improving diagnosis and prognosis in prostate cancer. See the Cancer Research article here.
The Kuhn and Hicks Laboratory at the USC Michelson Center for Convergent Bioscience (Los Angeles, CA) is looking for three postdoctoral fellows to focus on specific single cell and liquid biopsy projects in breast, lung and prostate cancer. Critical to being a successful candidate are the determination to improving outcomes for cancer patients through scientific... Read More
USC’s Convergent Science Initiative in Cancer and the USC Jimmy Iovine and Andre Young Academy have developed a new interdisciplinary undergraduate track to launch in the fall of 2019. Students in this new educational track will interact with physicians, scientists, patients and graduate students to develop innovative health solutions. Click here to read more.
Dr. Peter Kuhn and Dr. Valery Folkin of the USC Michelson Center for Convergent Bioscience discuss the role of the new Michelson Center building and a supportive culture in encouraging interdisciplinary collaboration. Click here to read more.
Dr. James Hicks, professor of biologic sciences at the USC Michelson Center for Convergent Bioscience and professor at the Keck School of Medicine at USC, and Liya Xu, a postdoctoral fellow published work showing that the chromosomal changes in the DNA found in the eye’s aqueous humor parallel chromosomal changes found in the retinoblastoma tumor.... Read More
Dr. Peter Kuhn, Dean’s Professor of Biological Sciences and a founding member of the USC Michelson Center for Convergent Bioscience, traveled to Vietnam to discuss a multidisciplinary approach to understanding cancer evolution and forecasting an individual patient’s progress. One goal is to put the cancer patient at the center. Click here to read more.
USC Viterbi School alumnus,Thuy Truong, was diagnosed with lung cancer which motivated her to work on developing technology for patient-centric cancer management. Click here to read more.
The Kuhn laboratory at USC will lead a Public-Private Partnership launched by the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium to evaluate liquid biopsies as biomarker in patients with colorectal cancer undergoing hepatic metastasectomy using the HD-SCA platform.
Convergence science has been pioneered in the field of oncology. However, other fields, such as neuroscience and psychiatry, are picking up on this approach of dealing with complexity. READ MORE